Newsletter
Paroxetine vs Quetiapine and Hypercapnia, SARS-CoV-2 Vaccination and COVID-19 Outcomes, USPSTF Recommendation on Anxiety in Children and Adolescents, and more

JAMA Editor’s Summary

Paroxetine vs Quetiapine and Hypercapnia, SARS-CoV-2 Vaccination and COVID-19 Outcomes, USPSTF Recommendation on Anxiety in Children and Adolescents, and more

Editor’s Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief of JAMA, the Journal of the American Medical Association, for the , issue.
October 11, 2022
ADVERTISEMENT

Newer →

Spinal Cord Stimulation for Chronic Back Pain, Prescription Drug Spending in Medicare, USPSTF Recommendation on Screening for Depression and Suicide Risk in Children and Adolescents, and more

← Older

Antibiotics for Complicated Urinary Tract Infection, Telmisartan for Peripheral Artery Disease, Reducing Opioids After Arthroscopy, and more
Buffer LinkedIn WhatsApp

Paroxetine vs Quetiapine and Hypercapnia, SARS-CoV-2 Vaccination and COVID-19 Outcomes, USPSTF Recommendation on Anxiety in Children and Adolescents, and more

Editor’s Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief of JAMA, the Journal of the American Medical Association, for the October 11, 2022, issue.

ADVERTISEMENT
ADVERTISEMENT

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

We gratefully acknowledge the many organizations that have generously supported our podcasts and platform.

Silver Sponsors

Bronze Sponsors

Event and Media Partners

Buffer LinkedIn WhatsApp
00:00
00:00